Cargando…
The Many Faces of Huntington’s Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review
Huntington’s Disease (HD) is a rare, neurodegenerative disorder characterized by chorea, cognitive decline, and behavioral changes. Despite wide clinical use since the mid-1980s, tiapride was recently withdrawn from the Dutch market without rationale. Although alternatives are available, many patien...
Autores principales: | Feleus, Stephanie, van Schaijk, Malu, Roos, Raymund A. C., de Bot, Susanne T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025785/ https://www.ncbi.nlm.nih.gov/pubmed/35455705 http://dx.doi.org/10.3390/jpm12040589 |
Ejemplares similares
-
Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
por: Coppen, Emma M., et al.
Publicado: (2016) -
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington’s disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics
por: Feleus, Stephanie, et al.
Publicado: (2023) -
Tiapride for the Treatment of Auditory Hallucinations in Schizophrenia
por: Karia, Sagar, et al.
Publicado: (2013) -
The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972) -
More than a co-incidence? Comment on: Amyotrophic lateral sclerosis is over‐represented in two Huntington’s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion
por: Bakels, Hannah S., et al.
Publicado: (2022)